Funded Tech Companies
Proteolix
Headquartered in South San Francisco, Proteolix was acquired by Onyx Pharmaceuticals.
Company Overview
Company Name
Proteolix
Company Status
Acquired or Merged
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
333 Allerton Avenue
South San Francisco, CA 94080
USA
South San Francisco, CA 94080
USA
Phone
Website
Email Address
Company Background Information
Overview
Proteolix, Inc. is a biopharmaceutical company dedicated to discovering, developing and marketing pharmaceutical products that target the proteasome and the control of protein turnover in cells. The company's focus is on the treatment of cancer, inflammatory disease, and autoimmunity.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
12/31/2014
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Medical Officer
Michael Kauffman
Executive Vice President
Thomas Kassberg
Vice President
Mark Bennett
Vice President
Christopher Molineaux
VP - Finance
Craig Parker
VP - Regulatory Affairs
Albert Kraus
Company Investors
- Advanced Technology Ventures
- Nomura Phase4 Ventures (Denise Pollard-Knight)
- U.S. Venture Partners (Jonathan Root)
- The Vertical Group (Jack Lasersohn)
- Latterell Venture Partners
- Advanced Technology Ventures (Jean George)
- Delphi Ventures (Deepa Pakianathan)
- Latterell Venture Partners (Larry Lasky)
Browse more funded tech companies:
ProteoGuard | Proteon Therapeutics
Share this article
About Our Venture Capital Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs